Nutriband (NTRB) News Today $6.80 -0.03 (-0.44%) Closing price 03/25/2025 04:00 PM EasternExtended Trading$6.70 -0.10 (-1.47%) As of 03/25/2025 07:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Nutriband Inc. (NASDAQ:NTRB) Short Interest Down 22.1% in FebruaryNutriband Inc. (NASDAQ:NTRB - Get Free Report) was the recipient of a significant decline in short interest in the month of February. As of February 28th, there was short interest totalling 281,200 shares, a decline of 22.1% from the February 13th total of 361,000 shares. Currently, 5.5% of the shares of the company are short sold. Based on an average trading volume of 204,900 shares, the days-to-cover ratio is currently 1.4 days.March 18, 2025 | marketbeat.comNutriband Inc. (NASDAQ:NTRB) Short Interest UpdateNutriband Inc. (NASDAQ:NTRB - Get Free Report) saw a large increase in short interest in February. As of February 15th, there was short interest totalling 361,000 shares, an increase of 37.7% from the January 31st total of 262,100 shares. Based on an average daily volume of 202,200 shares, the short-interest ratio is presently 1.8 days. Approximately 7.1% of the company's stock are sold short.March 5, 2025 | marketbeat.comNutriband receives Certificate of Registration from USPTO for trademarkFebruary 21, 2025 | markets.businessinsider.comNutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.February 21, 2025 | globenewswire.comNoble Financial Sticks to Its Buy Rating for Nutriband (NTRB)February 14, 2025 | markets.businessinsider.comNutriband partners with Kindeva for opioid patch developmentFebruary 13, 2025 | msn.comNutriband, Kindeva Drug Delivery formalize exclusive development partnershipFebruary 13, 2025 | markets.businessinsider.comNutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl PatchFebruary 13, 2025 | globenewswire.comNutriband Inc. (NASDAQ:NTRB) Sees Large Growth in Short InterestNutriband Inc. (NASDAQ:NTRB - Get Free Report) was the target of a large growth in short interest in January. As of January 31st, there was short interest totalling 262,100 shares, a growth of 377.4% from the January 15th total of 54,900 shares. Currently, 5.1% of the shares of the stock are sold short. Based on an average daily volume of 181,900 shares, the days-to-cover ratio is presently 1.4 days.February 13, 2025 | marketbeat.comNutriband Inc. Announces Olympian Anastasia Nichita to Advisory BoardFebruary 11, 2025 | markets.businessinsider.comNutriband appoints Anastasia Nichita to advisory boardFebruary 11, 2025 | markets.businessinsider.comNutriband secures US patent for abuse deterrent patchFebruary 7, 2025 | msn.comNutriband receives notice of allowance for U.S. patent covering Aversa techFebruary 7, 2025 | markets.businessinsider.comNutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™February 7, 2025 | globenewswire.comWhy These 15 Healthcare Stocks Are Skyrocketing So Far In 2025February 3, 2025 | msn.comWhy Nutriband Inc (NTRB) Is Skyrocketing So Far In 2025February 3, 2025 | msn.comNutriBand Shareholders Approve Key Proposals at Annual MeetingJanuary 30, 2025 | msn.comNutriband initiated with an Outperform at Noble CapitalJanuary 24, 2025 | markets.businessinsider.comNutriband Inc trading halted, volatility trading pauseJanuary 24, 2025 | markets.businessinsider.comNoble Financial Comments on Nutriband FY2025 EarningsNutriband Inc. (NASDAQ:NTRB - Free Report) - Research analysts at Noble Financial issued their FY2025 earnings per share estimates for Nutriband in a note issued to investors on Wednesday, January 22nd. Noble Financial analyst R. Leboyer forecasts that the company will post earnings of ($0.60) peJanuary 24, 2025 | marketbeat.comNutriband Stock Soars to 52-Week High of $9.6 Amidst Strong GrowthJanuary 23, 2025 | msn.comNoble Capital Markets Initiates Coverage of Nutriband (NTRB) with Outperform RecommendationJanuary 23, 2025 | msn.comNoble Capital sets Nutriband stock Outperform with $13 targetJanuary 22, 2025 | msn.comNutriband (NASDAQ:NTRB) Now Covered by Analysts at Noble FinancialNoble Financial assumed coverage on shares of Nutriband in a research report on Wednesday. They issued an "outperform" rating and a $13.00 price target for the company.January 22, 2025 | marketbeat.comShareholders in Nutriband (NASDAQ:NTRB) are in the red if they invested five years agoJanuary 8, 2025 | finance.yahoo.comNutriband Issues Letter to ShareholdersDecember 31, 2024 | globenewswire.comNutriband Extends Chinese Patent to Macao for its AVERSA(TM) Abuse Deterrent Transdermal TechnologyDecember 29, 2024 | stockhouse.comNutriband Secures Patent for AVERSA™ Abuse-Deterrent Technology in 46 Countries, Plans FDA Filing for Fentanyl Patch in 2025December 29, 2024 | nasdaq.comNutriband extends Chinese patent to Macao for AVERSA technologyDecember 28, 2024 | finance.yahoo.comNutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal TechnologyDecember 27, 2024 | globenewswire.comNutriband reports record revenue for Q3, progress to NDA for AVERSADecember 5, 2024 | markets.businessinsider.comNutriband Inc. to Present at The 2024 Noble Conference in Boca Raton on December 4thDecember 4, 2024 | markets.businessinsider.comNutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025December 4, 2024 | globenewswire.comNutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal TechnologyNovember 27, 2024 | globenewswire.comNutriband Secures Chinese Patent for AVERSA™ TechnologyNovember 1, 2024 | markets.businessinsider.comNutriband issued CNIPA patent for abuse, misuse deterrent transdermal systemNovember 1, 2024 | markets.businessinsider.comNutriband (NASDAQ:NTRB) Stock Price Down 8.1% - Here's What HappenedNutriband (NASDAQ:NTRB) Stock Price Down 8.1% - Should You Sell?October 23, 2024 | marketbeat.comNutriband, Inc.: Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa RicaOctober 17, 2024 | finanznachrichten.deNutriband (NASDAQ:NTRB) Trading Up 0.7%Nutriband (NASDAQ:NTRB) Trading 0.7% HigherOctober 1, 2024 | marketbeat.comNutriband (NASDAQ: NTRB) Inks Licensing Agreement to Use Bitrex(R) for Flagship ProductSeptember 24, 2024 | theglobeandmail.comBioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Announces Receipt of Notice of Allowance for China Patent Application Covering AVERSA(TM) TechnologySeptember 24, 2024 | msn.comBioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Inks Licensing Agreement to Use Bitrex(R) Aversive Agent for Flagship ProductSeptember 20, 2024 | msn.comNutriband, Inc.: Nutriband Licenses Bitrex Brand Aversive Agent for Its Lead Product - Aversa Fentanyl Transdermal PatchSeptember 20, 2024 | finanznachrichten.deNutriband to repurchase $1 million in common stockSeptember 19, 2024 | uk.investing.comNutriband (NASDAQ:NTRB) Stock Quotes, Forecast and News SummarySeptember 17, 2024 | benzinga.comNutriband, Inc.: Nutriband Inc. Authorizes $1M Share Buyback ProgramSeptember 16, 2024 | finanznachrichten.deBioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Releases Q2 Report, AVERSA Fentanyl UpdateSeptember 5, 2024 | msn.comProposed US Law Would Direct Opioid Settlement Cash to Opioid Crisis ManagementAugust 29, 2024 | msn.comNutriband (NASDAQ:NTRB investor five-year losses grow to 80% as the stock sheds US$27m this past weekAugust 1, 2024 | finance.yahoo.comNutriband, Inc.: Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25July 20, 2024 | finanznachrichten.de Remove Ads Get Nutriband News Delivered to You Automatically Sign up to receive the latest news and ratings for NTRB and its competitors with MarketBeat's FREE daily newsletter. Email Address NTRB Media Mentions By Week NTRB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NTRB News Sentiment▼1.890.79▲Average Medical News Sentiment NTRB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NTRB Articles This Week▼11▲NTRB Articles Average Week Remove Ads Get Nutriband News Delivered to You Automatically Sign up to receive the latest news and ratings for NTRB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Pulmonx News AVITA Medical News Nevro News Electromed News Profound Medical News Lakeland Industries News Inogen News Alpha Tau Medical News Anteris Technologies Global News BrainsWay News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NTRB) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredThis Crypto Is Set to Explode in FebruaryBryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nutriband Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nutriband With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
